|
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1Professor of Dermatology and Chair, Department of Dermatology and Dermatologic Surgery, Medical University of South Carolina, Charleston, SC
2College of Medicine, Medical University of South Carolina, Charleston, SC
3Professor of Medicine and Chief, Division of Dermatology, University of Louisville School of Medicine, Louisville, KY
Corresponding author: Bruce H. Thiers, MD, Department of Dermatology and Dermatologic Surgery, Medical University of South Carolina, 135 Rutledge Avenue, 11th Floor, PO Box 250578, Charleston, SC 29425; e-mail: thiersb{at}musc.edu
To earn free CME credit or nursing contact hours for successfully completing the online quiz based on this article, go to http://CME.AmCancerSoc.org.
DISCLOSURES: The authors report no conflicts of interest.
The skin often mirrors changes in the organism it envelops. Many neoplastic diseases that affect internal organs display cutaneous manifestations, which may be the presenting signs and symptoms of the underlying malignancy. These may reflect direct involvement of the skin by the tumor (ie, tumor metastasis) or indirect involvement, in which changes in the skin occur in the absence of malignant cells. This review focuses on the latter conditions, which are often referred to as paraneoplastic dermatoses. Included in the discussion are the cutaneous manifestations of inherited syndromes that are associated with an increased risk of internal malignancy, cutaneous changes in patients with hormone-secreting tumors, and the wide spectrum of proliferative and inflammatory dermatoses that have been associated with internal cancer. CA Cancer J Clin 2009;59:73–98. © 2009 American Cancer Society, Inc.
Read all eLetters
eLetters:
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | COVER ARCHIVE | SEARCH | TABLE OF CONTENTS |